Exact Mass: 462.2465
Exact Mass Matches: 462.2465
Found 500 metabolites which its exact mass value is equals to given mass value 462.2465
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neryl rhamnosyl-glucoside
Constituent of wine grapes (Vitis vinifera). Geranyl rhamnosyl-glucoside is found in alcoholic beverages, fruits, and common grape. Neryl rhamnosyl-glucoside is found in alcoholic beverages. Neryl rhamnosyl-glucoside is isolated from wine grapes (Vitis vinifera
xi-Linalool 3-[rhamnosyl-(1->6)-glucoside]
xi-Linalool 3-[rhamnosyl-(1->6)-glucoside] is found in alcoholic beverages. xi-Linalool 3-[rhamnosyl-(1->6)-glucoside] is a constituent of wine grapes (Vitis vinifera) Constituent of wine grapes (Vitis vinifera). xi-Linalool 3-[rhamnosyl-(1->6)-glucoside] is found in alcoholic beverages, fruits, and common grape.
Retinyl beta-glucuronide
Retinyl beta-glucuronide is a natural human metabolite of retinoic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Retinyl beta-glucuronide is a natural human metabolite of retinoic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
Diazepinomicin
Sar-Pro-Arg-pNA
2beta,9alpha,14alpha-Triacetoxy-3alpha-hydroxy-1(15),8(19)-trinervitadiene
2-(4-Methyl-3-cyclohexen-1-yl)-2-propanyl 6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
(2RS,3SR)-3,4-dihydro-7-(6-hydroxybenzofuran-2-yl)-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)-2H-1-benzopyran-3,5-diol|artopetelin F
14,15,16-triacetoxy-15,16-epoxy-ent-cleroda-4(18),12E-diene
(2R)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-5,7-bis(3-methylbut-2-en-1-yl)-2,4-bi-1-benzofuran-6,6-diol|artonitidin A
1alpha-hydroxy-7alpha,14alpha,18-triacetoxy-isopimara-8,15-diene|7alpha,14alpha,18-triacetoxy-8,15-isopimaradien-1alpha-ol
artocarpol I|rel-(17R,18R)-3,4-dihydro-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)-2H-dibenzo[b.f]pyrano[2,3-d]oxepine-3alpha,7,11-triol
(1S,2R,3S,8S,9S,10S,13S,14S,16S,17R,22R,25R)-21-nor-18beta,27alpha-dimethyl-1beta,2beta,3beta-trihydroxy-25-spirost-4-en-19beta-oic acid
1-[1-(acetyloxy)ethyl]octahydro-6-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-7-(propan-2-yl)-1H-inden-5-yl (2E)-3-methylpent-2-enoate
2-epicaseabalansin C|rel-(2R,4S,5R,8S,9S,10R,18S,19R)-2,18,19-triacetoxycleroda-13(16),14-dien-18,19-oxolane
6alpha,17alpha-dihydroxy-15,17-oxidospongian-16-one 6-butyrate 17 acetate
methyl-4E-9beta-senecioyloxy-14-O-<2-methylbutyryl>-oxyphylloate|methyl-9beta-senecioyloxy-14-O-(2-methylbutyryl)-oxyphylloate|methyl-9beta-senecioyloxy-14-O-<2-methylbutyryl>-oxyphylloate
2-[2-(3,3-dimethyloxiran-2-yl)ethyl]-3,4-dihydro-6-(3-methylbut-2-enyl)-2H-dibenzo[b,f]pyrano[2,3-d]oxepin-7,11-diol|artocarpol G
5,14,19-Tri-Ac-(5R,13(15)E,16Z)-13(15),16-Spatadiene-5,14,18,19-tetrol
14,15,16-Triacetoxy-15,16-epoxy-ent-cleroda-3,12Z-diene
15-O-acetyl-5beta-hydroxyisocharaciol-3-isobutyrate
1,7-dihydroxy-3-methoxy-2-isoprenyl-4-geranylxanthone|pruniflorone L
6,12,13-Tri-Ac-(1alpha,5beta,6beta,9alpha,12xi,13xi)-3,10,14-Prenylguaiatriene-6,9,12,13-tetrol
C22H38O10_2-(4-Methyl-3-cyclohexen-1-yl)-2-propanyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
Ala His His Val
Ala His Val His
Ala Ile Pro Tyr
Ala Ile Tyr Pro
Ala Leu Pro Tyr
Ala Leu Tyr Pro
Ala Pro Ile Tyr
Ala Pro Leu Tyr
Ala Pro Tyr Ile
Ala Pro Tyr Leu
Ala Val His His
Ala Tyr Ile Pro
Ala Tyr Leu Pro
Ala Tyr Pro Ile
Ala Tyr Pro Leu
Cys Gly Lys Arg
Cys Gly Arg Lys
Cys Lys Gly Arg
Cys Lys Arg Gly
Cys Arg Gly Lys
Cys Arg Lys Gly
Glu Ile Thr Thr
Glu Leu Thr Thr
Glu Thr Ile Thr
Glu Thr Leu Thr
Glu Thr Thr Ile
Glu Thr Thr Leu
Phe Ile Pro Ser
Phe Ile Ser Pro
Phe Leu Pro Ser
Phe Leu Ser Pro
Phe Pro Ile Ser
Phe Pro Leu Ser
Phe Pro Ser Ile
Phe Pro Ser Leu
Phe Pro Thr Val
Phe Pro Val Thr
Phe Ser Ile Pro
Phe Ser Leu Pro
Phe Ser Pro Ile
Phe Ser Pro Leu
Phe Thr Pro Val
Phe Thr Val Pro
Phe Val Pro Thr
Phe Val Thr Pro
Gly Cys Lys Arg
Gly Cys Arg Lys
Gly His His Ile
Gly His His Leu
Gly His Ile His
Gly His Leu His
Gly Ile His His
Gly Lys Cys Arg
Gly Lys Arg Cys
Gly Leu His His
Gly Arg Cys Lys
Gly Arg Lys Cys
His Ala His Val
His Ala Val His
His Gly His Ile
His Gly His Leu
His Gly Ile His
His Gly Leu His
His His Ala Val
His His Gly Ile
His His Gly Leu
His His Ile Gly
His His Leu Gly
His His Val Ala
His Ile Gly His
His Ile His Gly
His Ile Pro Pro
His Leu Gly His
His Leu His Gly
His Leu Pro Pro
His Pro Ile Pro
His Pro Leu Pro
His Pro Pro Ile
His Pro Pro Leu
His Val Ala His
His Val His Ala
Ile Ala Pro Tyr
Ile Ala Tyr Pro
Ile Glu Thr Thr
Ile Phe Pro Ser
Ile Phe Ser Pro
Ile Gly His His
Ile His Gly His
Ile His His Gly
Ile His Pro Pro
Ile Ile Met Ser
Ile Ile Ser Met
Ile Leu Met Ser
Ile Leu Ser Met
Ile Met Ile Ser
Ile Met Leu Ser
Ile Met Ser Ile
Ile Met Ser Leu
Ile Met Thr Val
Ile Met Val Thr
Ile Pro Ala Tyr
Ile Pro Phe Ser
Ile Pro His Pro
Ile Pro Pro His
Ile Pro Ser Phe
Ile Pro Tyr Ala
Ile Ser Phe Pro
Ile Ser Ile Met
Ile Ser Leu Met
Ile Ser Met Ile
Ile Ser Met Leu
Ile Ser Pro Phe
Ile Thr Glu Thr
Ile Thr Met Val
Ile Thr Thr Glu
Ile Thr Val Met
Ile Val Met Thr
Ile Val Thr Met
Ile Tyr Ala Pro
Ile Tyr Pro Ala
Lys Cys Gly Arg
Lys Cys Arg Gly
Lys Gly Cys Arg
Lys Gly Arg Cys
Lys Asn Thr Thr
Lys Gln Ser Thr
Lys Gln Thr Ser
Lys Arg Cys Gly
Lys Arg Gly Cys
Lys Ser Gln Thr
Lys Ser Thr Gln
Lys Thr Asn Thr
Lys Thr Gln Ser
Lys Thr Ser Gln
Lys Thr Thr Asn
Leu Ala Pro Tyr
Leu Ala Tyr Pro
Leu Glu Thr Thr
Leu Phe Pro Ser
Leu Phe Ser Pro
Leu Gly His His
Leu His Gly His
Leu His His Gly
Leu His Pro Pro
Leu Ile Met Ser
Leu Ile Ser Met
Leu Leu Met Ser
Leu Leu Ser Met
Leu Met Ile Ser
Leu Met Leu Ser
Leu Met Ser Ile
Leu Met Ser Leu
Leu Met Thr Val
Leu Met Val Thr
Leu Pro Ala Tyr
Leu Pro Phe Ser
Leu Pro His Pro
Leu Pro Pro His
Leu Pro Ser Phe
Leu Pro Tyr Ala
Leu Ser Phe Pro
Leu Ser Ile Met
Leu Ser Leu Met
Leu Ser Met Ile
Leu Ser Met Leu
Leu Ser Pro Phe
Leu Thr Glu Thr
Leu Thr Met Val
Leu Thr Thr Glu
Leu Thr Val Met
Leu Val Met Thr
Leu Val Thr Met
Leu Tyr Ala Pro
Leu Tyr Pro Ala
Met Ile Ile Ser
Met Ile Leu Ser
Met Ile Ser Ile
Met Ile Ser Leu
Met Ile Thr Val
Met Ile Val Thr
Met Leu Ile Ser
Met Leu Leu Ser
Met Leu Ser Ile
Met Leu Ser Leu
Met Leu Thr Val
Met Leu Val Thr
Met Ser Ile Ile
Met Ser Ile Leu
Met Ser Leu Ile
Met Ser Leu Leu
Met Thr Ile Val
Met Thr Leu Val
Met Thr Val Ile
Met Thr Val Leu
Met Val Ile Thr
Met Val Leu Thr
Met Val Thr Ile
Met Val Thr Leu
Asn Lys Thr Thr
Asn Thr Lys Thr
Asn Thr Thr Lys
Pro Ala Ile Tyr
Pro Ala Leu Tyr
Pro Ala Tyr Ile
Pro Ala Tyr Leu
Pro Phe Ile Ser
Pro Phe Leu Ser
Pro Phe Ser Ile
Pro Phe Ser Leu
Pro Phe Thr Val
Pro Phe Val Thr
Pro His Ile Pro
Pro His Leu Pro
Pro His Pro Ile
Pro His Pro Leu
Pro Ile Ala Tyr
Pro Ile Phe Ser
Pro Ile His Pro
Pro Ile Pro His
Pro Ile Ser Phe
Pro Ile Tyr Ala
Pro Leu Ala Tyr
Pro Leu Phe Ser
Pro Leu His Pro
Pro Leu Pro His
Pro Leu Ser Phe
Pro Leu Tyr Ala
Pro Pro His Ile
Pro Pro His Leu
Pro Pro Ile His
Pro Pro Leu His
Pro Ser Phe Ile
Pro Ser Phe Leu
Pro Ser Ile Phe
Pro Ser Leu Phe
Pro Thr Phe Val
Pro Thr Val Phe
Pro Val Phe Thr
Pro Val Thr Phe
Pro Tyr Ala Ile
Pro Tyr Ala Leu
Pro Tyr Ile Ala
Pro Tyr Leu Ala
Gln Lys Ser Thr
Gln Lys Thr Ser
Gln Ser Lys Thr
Gln Ser Thr Lys
Gln Thr Lys Ser
Gln Thr Ser Lys
Arg Cys Gly Lys
Arg Cys Lys Gly
Arg Gly Cys Lys
Arg Gly Lys Cys
Arg Lys Cys Gly
Arg Lys Gly Cys
Ser Phe Ile Pro
Ser Phe Leu Pro
Ser Phe Pro Ile
Ser Phe Pro Leu
Ser Ile Phe Pro
Ser Ile Ile Met
Ser Ile Leu Met
Ser Ile Met Ile
Ser Ile Met Leu
Ser Ile Pro Phe
Ser Lys Gln Thr
Ser Lys Thr Gln
Ser Leu Phe Pro
Ser Leu Ile Met
Ser Leu Leu Met
Ser Leu Met Ile
Ser Leu Met Leu
Ser Leu Pro Phe
Ser Met Ile Ile
Ser Met Ile Leu
Ser Met Leu Ile
Ser Met Leu Leu
Ser Pro Phe Ile
Ser Pro Phe Leu
Ser Pro Ile Phe
Ser Pro Leu Phe
Ser Gln Lys Thr
Ser Gln Thr Lys
Ser Thr Lys Gln
Ser Thr Gln Lys
Thr Glu Ile Thr
Thr Glu Leu Thr
Thr Glu Thr Ile
Thr Glu Thr Leu
Thr Phe Pro Val
Thr Phe Val Pro
Thr Ile Glu Thr
Thr Ile Met Val
Thr Ile Thr Glu
Thr Ile Val Met
Thr Lys Asn Thr
Thr Lys Gln Ser
Thr Lys Ser Gln
Thr Lys Thr Asn
Thr Leu Glu Thr
Thr Leu Met Val
Thr Leu Thr Glu
Thr Leu Val Met
Thr Met Ile Val
Thr Met Leu Val
Thr Met Val Ile
Thr Met Val Leu
Thr Asn Lys Thr
Thr Asn Thr Lys
Thr Pro Phe Val
Thr Pro Val Phe
Thr Gln Lys Ser
Thr Gln Ser Lys
Thr Ser Lys Gln
Thr Ser Gln Lys
Thr Thr Glu Ile
Thr Thr Glu Leu
Thr Thr Ile Glu
Thr Thr Lys Asn
Thr Thr Leu Glu
Thr Thr Asn Lys
Thr Val Phe Pro
Thr Val Ile Met
Thr Val Leu Met
Thr Val Met Ile
Thr Val Met Leu
Thr Val Pro Phe
Val Ala His His
Val Phe Pro Thr
Val Phe Thr Pro
Val His Ala His
Val His His Ala
Val Ile Met Thr
Val Ile Thr Met
Val Leu Met Thr
Val Leu Thr Met
Val Met Ile Thr
Val Met Leu Thr
Val Met Thr Ile
Val Met Thr Leu
Val Pro Phe Thr
Val Pro Thr Phe
Val Thr Phe Pro
Val Thr Ile Met
Val Thr Leu Met
Val Thr Met Ile
Val Thr Met Leu
Val Thr Pro Phe
Tyr Ala Ile Pro
Tyr Ala Leu Pro
Tyr Ala Pro Ile
Tyr Ala Pro Leu
Tyr Ile Ala Pro
Tyr Ile Pro Ala
Tyr Leu Ala Pro
Tyr Leu Pro Ala
Tyr Pro Ala Ile
Tyr Pro Ala Leu
Tyr Pro Ile Ala
Tyr Pro Leu Ala
Neryl rhamnosyl-glucoside
xi-Linalool 3-[rhamnosyl-(1->6)-glucoside]
Vistusertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes. Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes.
Diazepinomicin
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
Tixocortol pivalate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D018926 - Anti-Allergic Agents
Amelometasone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate
Arg-Lys-Cys-Gly
A tetrapeptide composed of L-arginine, L-lysine, L-cysteine, and glycine joined in sequence by peptide linkages.
(2R)-2-[(4S,5R)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
p-Mentha-1-ene-8-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside
2,3-dihydroxypropyl [3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-hydroxypropyl] hydrogen phosphate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-)
A docosanoid anion obtained by deprotonation of the two carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.
AGI-5198
AGI-5198 (IDH-C35) is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0.07 μM.
(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5r,6r)-2-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol
2-[11-(4-hydroperoxy-4-methylpent-2-en-1-yl)-3-methoxy-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(1e)-2-[(1s,2s,7s)-2-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
methyl (2s,3ar,4s,5s,5'as,7's,9'ar)-3a-(hydroxymethyl)-1',1',4,5'a,7,7'-hexamethyl-3',6-dioxo-4,4',5,5',7',8',9',9'a-octahydro-3h-spiro[1-benzofuran-2,6'-[2]benzoxepine]-5-carboxylate
2-[7-hydroxy-2,2-dimethyl-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-5-yl]-7-(3-methylbut-3-en-2-yl)-1-benzofuran-4,6-diol
{2-hydroxy-6-[1-hydroxy-3-methyl-5-(1,2,6-trimethylcyclohex-2-en-1-yl)pent-2-en-1-yl]-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl}methyl 3-hydroxybutanoate
2-[3,5-dihydroxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl]-7-[(2r)-3-methylbut-3-en-2-yl]-1-benzofuran-4,6-diol
2-[2-(4-hydroperoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,7-dihydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)xanthen-9-one
7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-[(2r)-6-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-4-yl]-1-benzofuran-6-ol
10-deacetyltaxuyunnanine c
{"Ingredient_id": "HBIN000092","Ingredient_name": "10-deacetyltaxuyunnanine c","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4787","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-o-methyl-5-epi-vibsanin k
{"Ingredient_id": "HBIN002145","Ingredient_name": "18-o-methyl-5-epi-vibsanin k","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C(=CCC1(C)CC=CC(C)(C)OO)COC)CC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14397","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-o-methylvibsanin k
{"Ingredient_id": "HBIN002148","Ingredient_name": "18-o-methylvibsanin k","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C(=CCC1(C)CC=CC(C)(C)OO)COC)CC(=O)C)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10695370","DrugBank_id": "NA"}
1-dehydroxybaccatin
{"Ingredient_id": "HBIN002472","Ingredient_name": "1-dehydroxybaccatin","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC1=C2C(CC3(C(CC(C2(C)C)CC1OC(=O)C)C4COC4CC3OC(=O)C)C)OC(=O)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25938","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101225011","DrugBank_id": "NA"}
2alpha-hydroxy-5alpha,10beta,14beta-triacetoxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN005284","Ingredient_name": "2alpha-hydroxy-5alpha,10beta,14beta-triacetoxytaxa-4(20),11-diene","Alias": "2\u03b1-hydroxy-5\u03b1,10\u03b2,14\u03b2-triacetoxytaxa-4(20),11-diene","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC1=C2C(CC3(CCC(C(=C)C3C(C(C2(C)C)C(C1)OC(=O)C)O)OC(=O)C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31281;10778","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-epi-neovibsanin d
{"Ingredient_id": "HBIN013182","Ingredient_name": "7-epi-neovibsanin d","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(CC=C2C13C(CC(O3)(C)OC)OC2)(C)CC=CC(C)(C)OO)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15464","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11385697","DrugBank_id": "NA"}